Completed PHASE4 INTERVENTIONAL 2-arm NCT02271191

Effect of Nicardipine on Renal Function in Deliberate Hypotension

Sponsor: Yonsei University

Interventions Nicardipine

Updated 5 times since 2017 Last updated: Oct 21, 2014 Started: May 31, 2012 Primary completion: Jan 31, 2013 Completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02271191, this PHASE4 trial focuses on Spinal Stenosis and remains completed. Sponsored by Yonsei University, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yonsei University

Data source: Yonsei University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.